Key result
Percutaneous pericardiotomy sustains 4-week hemodynamic benefits without excessive remodeling in a HFpEF swine model.
Why the study?
While acute pericardiotomy attenuates the rise in left ventricular end-diastolic pressure with volume loading in HFpEF, whether these effects are sustained chronically remains unknown.
Does minimally invasive percutaneous pericardiotomy provide sustained improvement in hemodynamics in a porcine model of heart failure with preserved ejection fraction?
Does minimally invasive percutaneous pericardiotomy provide sustained improvement in hemodynamics in a porcine model of heart failure with preserved ejection fraction?
Percutaneous pericardiotomy provides sustained improvement in diastolic reserve without adverse remodeling in a porcine model of HFpEF, supporting future human trials.
BACKGROUND: Heart failure with preserved ejection fraction is increasing in prevalence, but few effective treatments are available. Elevated left ventricular (LV) diastolic filling pressures represent a key therapeutic target. Pericardial restraint contributes to elevated LV end-diastolic pressure, and acute studies have shown that pericardiotomy attenuates the rise in LV end-diastolic pressure with volume loading. However, whether these acute effects are sustained chronically remains unknown. METHODS: Minimally invasive pericardiotomy was performed percutaneously using a novel device in a porcine model of heart failure with preserved ejection fraction. Hemodynamics were assessed at baseline and following volume loading with pericardium intact, acutely following pericardiotomy, and then again chronically after 4 weeks. Cardiac structure was assessed by magnetic resonance imaging. RESULTS: =0.28 versus acute). There was no statistically significant effect of pericardiotomy on ventricular remodeling compared with age-matched controls. None of the animals developed hemodynamic or pathological indicators of pericardial constriction or frank systolic dysfunction. CONCLUSIONS: The acute hemodynamic benefits of pericardiotomy are sustained for at least 4 weeks in a swine model of heart failure with preserved ejection fraction, without excessive chamber remodeling, pericarditis, or clinically significant systolic dysfunction. These data support trials evaluating minimally invasive pericardiotomy as a novel treatment for heart failure with preserved ejection fraction in humans.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2021) studied Heart failure with preserved ejection fraction. Minimally invasive percutaneous pericardiotomy vs. Baseline (pericardium intact) and age-matched controls was evaluated on Hemodynamics following volume loading and cardiac structure (p==0.28). Percutaneous pericardiotomy sustained acute hemodynamic benefits for at least 4 weeks in a swine model of heart failure with preserved ejection fraction, without excessive chamber remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: